✦ LIBER ✦

Vaginal Film Drug Delivery of the Pyrimidinedione IQP-0528 for the Prevention of HIV Infection

✍ Scribed by Anthony S. Ham, Lisa Cencia Rohan, Ashlee Boczar, Lu Yang, Karen W. Buckheit, Robert W. Buckheit Jr.

Book ID: 113077693
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 416 KB
Volume: 29
Category: Article
ISSN: 0724-8741
DOI: 10.1007/s11095-012-0715-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of the Dual-Acting Pyrimidin

Development of the Dual-Acting Pyrimidinedione IQP0528 as a Vaginal Topical Anti-HIV Microbicide

✍ Karen M. Watson; Lu Yang; Christa E. Buckheit; Robert W. Buckheit Jr. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Development of a combination microbicide

Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection

✍ Anthony S. Ham; Shweta R. Ugaonkar; Lianjun Shi; Karen Watson Buckheit; Howard L 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB

A Review of Current Intravaginal Drug De

A Review of Current Intravaginal Drug Delivery Approaches Employed for the Prophylaxis of HIV/AIDS and Prevention of Sexually Transmitted Infections

✍ Valence M. K. Ndesendo; Viness Pillay; Yahya E. Choonara; Eckhart Buchmann; Davi 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 497 KB

Risk factors of preterm delivery in HIV-

Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV

✍ Patrinee Traisathit; Jean Yves Mary; Sophie Le Cœur; Sudanee Thantanarat; Sivapo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Systemic and Topical Drugs for the Preve

Systemic and Topical Drugs for the Prevention of HIV Infection: Antiretroviral Pre-exposure Prophylaxis

✍ Baeten, Jared; Celum, Connie 📂 Article 📅 2013 🏛 Annual Reviews 🌐 English ⚖ 209 KB

Pre-exposure prophylaxis (PrEP), in which HIV-uninfected persons use oral or topical antiretroviral medications to protect against HIV acquisition, is a promising new HIV prevention strategy. The biologic rationale for evaluation of PrEP for sexual HIV prevention included nonhuman primate models and

PRO2000 vaginal gel for prevention of HI

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

✍ Sheena McCormack; Gita Ramjee; Anatoli Kamali; Helen Rees; Angela M Crook; Mitzy 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 205 KB